Toshihiro Maeda

Title: Innovations by Toshihiro Maeda

Introduction

Toshihiro Maeda is a notable inventor based in Kikuchi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of methods related to monoclonal antibodies and allergen purification. With a total of 3 patents, his work has the potential to impact medical treatments and allergy management.

Latest Patents

One of Maeda's latest patents is a method for enhancing the efficacy of monoclonal antibody preparations. This method involves testing antigens from patients for their reactivity with the antibody. By deducing an amino acid sequence from a nucleotide sequence obtained from a biopsy, the method assesses the suitability of patients for monoclonal antibody administration. Another significant patent is a method for purifying a modified major mite allergen. This process utilizes genetic recombination techniques and includes several purification steps, ultimately yielding a highly pure modified major mite allergen.

Career Highlights

Toshihiro Maeda is affiliated with the Juridical Foundation the Chemo-sero-therapeutic Research Institute. His work at this institution has allowed him to focus on innovative research in therapeutic applications. His contributions have been recognized within the scientific community, particularly in the areas of immunology and allergen research.

Collaborations

Maeda has collaborated with notable colleagues such as Toshio Murakami and Hiroshi Mizokami. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

Toshihiro Maeda's innovative work in biotechnology, particularly in monoclonal antibody preparations and allergen purification, showcases his commitment to advancing medical science. His patents reflect a dedication to improving patient outcomes and addressing significant health challenges.